Loading clinical trials...
Loading clinical trials...
Genetic and Epigenetic Contribution to Increased Risk of T2D in the UAE
Conditions
Locations
1
United Arab Emirates
Imperial College London Diabetes Centre
Abu Dhabi, United Arab Emirates
Start Date
March 23, 2016
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2022
Last Updated
February 17, 2020
NCT07472881
NCT01143454
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
Imperial College London Diabetes Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions